Skip to main content
Caplight Logo









Apreo Health

Apreo Health

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://apreohealth.com/

Last Round

Corporate Funding

May 13, 2026

Total Funding Raised

$153M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Apreo Health is a medical device company developing a tissue-sparing treatment for severe emphysema.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

emphysema treatmentCOPD treatmentairway scaffoldmedical devicebronchoscopic implantCOPDinterventional pulmonologyminimally invasive procedurenitinol implanttissue-sparing therapycollateral ventilationlung hyperinflationairway stentFDA breakthrough deviceclinical stage medtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apreo Health Comparables

Compare Apreo Health with similar companies based on industry and business-model similarity.

Apreo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cortex, Inc.
79%
Pulmonx
78%
Olympus Corporation
74%

Apreo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 13, 2026
Series BAug 7, 2025

Key People

Founding team and executive leadership

Martin Mayse

Co-Founder, Chief Scientific Officer, Board Member

Founding Team

Patrick Wu

Chief Technology Officer

Executive Team

Edward Enyeart

Chief Financial Officer

Executive Team

Jonathan Porter

Chief Product Officer

Executive Team

Apreo Health Investors

Notable investors and investment history

Apreo Health investors
InvestorRounds
Bain Capital Life SciencesSeries B
Lightstone VenturesSeries B, Series A
Santé VenturesSeries B, Series A
Norwest Venture PartnersSeries B
Intuitive VenturesSeries B
F-Prime CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2026

    Grew 30% QoQ, from 27 to 35 employees.

  • Jun 28, 2026

    Grew 33% QoQ, from 24 to 32 employees.

Apreo Health Filings

Explore SEC and related filing metadata, where available.

Apreo Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apreo Health's valuation, stock price, and market status.

Is Apreo Health a public or private company?

Apreo Health is a private company.

What is the current stock price of Apreo Health?

Apreo Health is a private company with no public stock price. No recent secondary market data is available.

How much is Apreo Health worth (valuation)?

Valuation information for Apreo Health is not publicly available.

Can I buy Apreo Health stock?

Apreo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Apreo Health's last funding round?

Apreo Health's most recent funding round was Corporate Funding on May 13, 2026.

Who are the main investors in Apreo Health?

Key investors in Apreo Health include Bain Capital Life Sciences, Norwest Venture Partners.

Will Apreo Health IPO soon?

No public IPO plans have been announced for Apreo Health.

How can I track Apreo Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apreo Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range35
Year Founded2021
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?